From the Editor - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
From the Editor
1234567
Next »

DIY Healthcare Reform

November 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.

Quality by Enforcement

September 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

After years of promomting QbD concepts, FDA's ready to take action on nonconformers.

Of Hubris and Happy Endings

August 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

Individuals and companies at the top seem to have no problem short-circuiting their success.

The Good Society

July 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

Is it good policy to pay for bad behavior?

Truth and Transparency

June 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

Misleading the public about their investments—be it money or medicine—is unacceptable.

Parallel Tracks

April 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

Obama's cost-containment and science-innovation initiatives need to overlap.

Whither FDA?

February 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

FDA's role should not be overlooked as it has been in years past.

A New Start for New Cells

January 2, 2009
By:Michelle Hoffman
Pharmaceutical Technology

The incoming administration has renewed hope for stem cells, but less adequate copycats may follow.

A Tale of Two Pharmaceutical Industries

December 2, 2008
By:Michelle Hoffman
Pharmaceutical Technology

China's quality approach to domestic versus exported products seems to be a lose-lose situation.

1234567
Next »

ADVERTISEMENT

LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
25%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
59%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
FindPharma Custom Search
Featured Jobs

More Jobs

Click here